Europe’s private markets are becoming more accessible as regulation evolves and investor demand expands. With opportunities across private equity, credit, infrastructure and real assets, these markets can offer diversification, income and long-term growth potential.
European private markets deserve closer attention because they bring together two powerful GMP themes: the steady expansion of private assets and investors’ search for differentiated returns and diversification beyond listed equities and bonds. While they remain a modest share of the GMP, they offer access to parts of the economy that public markets do not fully capture.
ELTIF 2.0 adds further momentum by making private-market access more scalable across Europe: lowering barriers for retail investors, broadening eligible assets, easing portfolio restrictions and giving managers greater flexibility to build semi-liquid or long-term vehicles. Together with the UK’s LTAF and Luxembourg’s UCI Part II framework, this should help direct more capital towards infrastructure, SMEs, the green transition and the real economy. The opportunity is not simply broader access, but the deepening and improvement of the investor base for European private markets. That said, complexity, uneven harmonization, investor education and AML/KYC requirements mean adoption is likely to build gradually rather than immediately.
Private capital’s long-term appeal is clearest when set against public equities. Over the past 25 years, the total return of global private capital, net of fees, was 10.4% annually, ahead of both MSCI World and the S&P 500, with the latter returning 8.9%. Over the past five years, from 2021 to 2025, MSCI World’s annualized return of 12.7% exceeded private capital’s 10.7%. However, private capital continues to offer a higher long-term return profile than broad listed equity markets.
The regional picture also supports the case for Europe. European private capital delivered 12.3% annualized returns over 2001–2025, ahead of North America and Asia and well above MSCI Europe’s 6.0%, highlighting a durable private-market premium over listed European equities. This advantage was strongest in 2001–2005 and 2016–2020, when returns reached 14.8% and 14.7%, respectively.
More recently, for the period 2021–25, MSCI Europe outperformed European private capital as listed markets recovered faster, while European private capital faced pressure from higher rates, valuation resets and slower exits. For the same period, the US led across both public and private markets, supported by stronger technology exposure, deeper capital markets and more scalable growth opportunities. For investors, the implication is selective allocation: Europe’s long-term private-market record remains compelling, but recent dispersion and exit constraints make manager, sector and strategy selection more important than broad regional exposure.
Europe-focused private equity is estimated at USD 1.6 trillion, or 15.6% of global private equity. Most of this exposure is managed by European-based firms: Europe-managed funds with a European focus are estimated at almost USD 1.5 trillion as of September 2025, equivalent to around 0.7% of the GMP, slightly below the 0.8% average in 2022–2024 but above the pre-COVID level of 0.5% (December 2019).
European private equity has grown in importance, but not as quickly as the wider investment universe. Its share of the GMP has slipped slightly, which means investors are interested, but allocations remain measured. The case for exposure is still improving, supported by diversification benefits, lower relative valuations and long-term themes such as energy transition, digital infrastructure and technology resilience. Put simply, European private equity is best used as a targeted allocation, not as a broad substitute for public equities. It remains small in overall portfolios, but it gives investors access to opportunities that listed markets may miss, including mid-market companies, consolidation plays and sectors such as digitalization, AI, healthcare and defence.
The return profile reinforces this selective allocation case. In core private equity excluding venture capital, Europe led regional performance over 2001–2025, with annualized returns of 13.62% versus 12.61% in North America. Returns were especially strong in 2001–2005 and 2016–2020, and although they moderated to 10.73% in 2021–2025, Europe still compared favorably with Asia’s 5.28%.
Venture capital adds a more cyclical but increasingly supportive layer to this story. After the early-2000s downturn, European VC has delivered sustained positive performance since 2006 and recorded the strongest regional long-term returns, at 6.36% annually over 2001–2025. Europe also outperformed North America and the overall VC market in four of the five periods, suggesting that the innovation ecosystem is becoming a more meaningful part of Europe’s private equity opportunity set.
Beyond performance, Europe’s private equity market has also become more geographically diversified. West Europe excluding the UK has become the dominant allocation, with its share rising from 24.6% to 47.2% since December 2000, a gain of 22.6 percentage points.
The UK has moved in the opposite direction, with its share falling from 64.7% to 37.8%, a decline of 26.9 percentage points. Together, these shifts point to a market moving away from its historically UK-centric base towards a broader continental opportunity set.
Other regions have changed more modestly. The Nordic region has gained share, reaching 13.5%, supported by technology, healthcare and sustainability-linked themes, while Central and East Europe remains small at 1.5% and has weakened slightly over the longer term.
Fundraising confirms the structural broadening, although the cycle is now normalising. European-focused private equity funds managed from Europe raised a record USD 200 billion in 2024, before falling 8.6% in 2025, with West Europe excluding the UK driving much of the strength while the UK and Nordic region declined sharply.
Even after this pullback, aggregate capital raised reached USD 182.9 billion in 2025, up USD 150.9 billion since 2000. West Europe excluding the UK is now the main fundraising region, accounting for USD 106.6 billion, or 58% of 2025 capital raised. The market is therefore structurally much larger and more continental than in the early 2000s, even as activity cools after an exceptionally strong cycle.
European private debt remains a small GMP allocation, representing less than 0.2% at end-2025 (Source: Preqin, European Private Markets, Q4 2025) and roughly 20% of global private debt exposure. The market is highly concentrated, with UK-based, Europe-focused firms accounting for more than 65% of regional AUM and averaging 65% of capital raised over the past 10 years. Lower valuations are supporting deal activity and lending opportunities while the UK’s strong debt-contract framework reinforces its leadership and makes a near-term shift in position unlikely.
Private debt has delivered stable annualized returns of around 7.5–10.5%, reinforcing its defensive role within private markets. Europe has been a steadier but lower-returning segment, typically generating 7.55–8.41% and trailing North America by around 1.5 percentage points over the long term (2011–25). The gap narrowed in 2016–2020, when Europe returned 8.41% versus 7.54% for North America, but widened again in 2021–2025 as rising rates lifted overall private debt returns to 9.59% and North America to 10.34%. Even so, Europe’s consistent return profile highlights the role of private debt as a resilient income-oriented allocation, albeit with less upside than the region’s private equity and venture capital markets.
Recent deal activity adds another perspective: Europe’s private debt market is broad by deal count but concentrated by value in a small number of large public-to-private transactions. In 2025, public-to-private deals totalled USD 8.8 billion, far ahead of add-ons at USD 1.4 billion and buyouts at USD 0.4 billion, despite only three transactions. By count, buyouts led with 52 deals, just ahead of add-ons at 51, followed by growth capital at 14 and corporate investment at one. For investors, the key is to balance access to large public-to-private deals with diversification across smaller buyouts and add-ons.
Overall, European private debt remains a niche allocation in macro-portfolio terms, but its strategic relevance is rising as the asset class fills financing gaps left by more constrained bank lending, offers investors exposure to senior, income-generating and often floating-rate credit, and provides a differentiated source of portfolio diversification. Europe-focused private debt has increased from 33.2% of the total AUM in 2020 (the sum of European HY, levered loan private debt) to 41.3% in 2025.
Europe’s private-market proposition rests on a clear but selective opportunity: access to parts of the economy that listed markets only partly capture, supported by long-term structural themes, regulatory innovation and a broadening investor base. Private assets remain a modest share of the GMP, but they sit at the intersection of two important portfolio needs: differentiated return sources and diversification beyond public equities and bonds. ELTIF 2.0, alongside the UK’s LTAF and Luxembourg’s UCI Part II framework, should help make private-market access more scalable across Europe and channel more capital into infrastructure, SMEs and the green transition, although adoption is likely to build gradually given implementation complexity, uneven harmonization and investor education needs. The case is strongest where exposure is targeted: European private capital has delivered a durable long-term premium over listed European equities, Europe has led regional performance in core private equity over 2001–2025, and the market has become more continental, with West Europe excluding the UK now the dominant allocation and fundraising region. At the same time, recent dispersion, valuation resets and slower exits argue against broad regional beta. Private debt adds a steadier income-oriented profile, supported by senior lending and the UK’s deep debt-contract framework, but it remains a niche GMP allocation with lower upside than private equity and venture capital. For investors, Europe’s proposition is therefore not simply more access to private markets; it is disciplined exposure to managers, sectors and strategies that can capture regional breadth, structural growth and regulatory change while managing liquidity, implementation and market-fragmentation risks.